64 related articles for article (PubMed ID: 38627714)
1. YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro study.
Li Z; Lu W; Yin F; Huang A
Transl Oncol; 2024 Jul; 45():101965. PubMed ID: 38688048
[TBL] [Abstract][Full Text] [Related]
2. A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma.
Qin X; Sun H; Hu S; Pan Y; Wang S
BMC Med Genomics; 2024 Apr; 17(1):88. PubMed ID: 38627714
[TBL] [Abstract][Full Text] [Related]
3. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
4. Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma.
Wang J; Han K; Li Y; Zhang C; Cui WH; Zhu LH; Luo T; Bian CJ
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8945-8958. PubMed ID: 36524514
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
7. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.
Zhang B; Tang B; Gao J; Li J; Kong L; Qin L
J Transl Med; 2020 Sep; 18(1):342. PubMed ID: 32887635
[TBL] [Abstract][Full Text] [Related]
8. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma.
Chen D; Aierken A; Li H; Chen R; Ren L; Wang K
Front Immunol; 2023; 14():1232390. PubMed ID: 37881434
[TBL] [Abstract][Full Text] [Related]
9. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.
Cheng Z; Huang H; Li M; Liang X; Tan Y; Chen Y
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242427
[TBL] [Abstract][Full Text] [Related]
10. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.
Chen Y; Tang L; Huang W; Abisola FH; Zhang Y; Zhang G; Yao L
Biol Direct; 2023 Feb; 18(1):4. PubMed ID: 36750831
[TBL] [Abstract][Full Text] [Related]
11. CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway.
Chen E; He Y; Jiang J; Yi J; Zou Z; Song Q; Ren Q; Lin Z; Lu Y; Liu J; Zhang J
Exp Hematol Oncol; 2023 Jan; 12(1):9. PubMed ID: 36639822
[TBL] [Abstract][Full Text] [Related]
12. Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma.
Wu D; Zhang C; Liao G; Leng K; Dong B; Yu Y; Tai H; Huang L; Luo F; Zhang B; Zhan T; Hu Q; Tai S
Cell Mol Biol Lett; 2022 Nov; 27(1):105. PubMed ID: 36447138
[TBL] [Abstract][Full Text] [Related]
13. MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma.
Wang X; Zhang P; Deng K
Anal Cell Pathol (Amst); 2022; 2022():1435173. PubMed ID: 36033372
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]